In utero exposure to benzo(a)pyrene predisposes offspring to cardiovascular dysfunction in later-life

G E Jules1, S Pratap, A Ramesh

  • 1Department of Neuroscience and Pharmacology, Environmental-Health Disparities and Medicine, Center for Molecular and Behavioral Neuroscience, Meharry Medical College, Nashville, TN 37208, USA.

Toxicology
|March 1, 2012
PubMed

Insights

In utero exposure to benzo(a)pyrene (B(a)P) can lead to elevated blood pressure in offspring. This study investigated B(a)P

Area of Science:

  • Environmental Toxicology
  • Developmental Biology
  • Cardiovascular Physiology

Background:

  • Benzo(a)pyrene (B(a)P), a polycyclic aromatic hydrocarbon, is a common environmental pollutant.
  • In utero exposure to B(a)P is suspected to disrupt fetal cardiovascular development.

Purpose of the Study:

  • To investigate the impact of in utero benzo(a)pyrene (B(a)P) exposure on cardiovascular development in Long Evans Hooded (LEH) rat offspring.
  • To identify molecular mechanisms underlying potential B(a)P-induced cardiovascular dysfunction.

Main Methods:

  • Timed-pregnant LEH rats were exposed to varying doses of B(a)P or diluent via oral gavage from embryonic day 14 to 17.
  • Offspring cardiovascular parameters, including systolic blood pressure, were assessed postnatally.
  • Gene expression analysis using microarray and quantitative real-time PCR was performed on cardiovascular tissues.

Main Results:

  • In utero B(a)P exposure did not affect litter size or pre-weaning growth.
  • Offspring exposed to middle and high doses of B(a)P exhibited significantly elevated systolic blood pressure at postnatal day 53.
  • Upregulation of mRNA expression for angiotensin (AngII), angiotensinogen (AGT), and endothelial nitric oxide synthase (eNOS) was observed in exposed offspring.

Conclusions:

  • In utero exposure to benzo(a)pyrene (B(a)P) may predispose offspring to cardiovascular deficits.
  • Elevated systolic blood pressure in B(a)P-exposed offspring is associated with altered expression of key cardiovascular regulatory genes.
  • These findings suggest potential long-term cardiovascular dysfunction resulting from prenatal B(a)P exposure.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pedigree Analysis01:35

Pedigree Analysis

Overview
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...